- Home
- ALAB vs FMS Comparison
ALAB vs FMS Comparison
Compare ALAB & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAB
- FMS
- Stock Information
- Founded
- ALAB 2017
- FMS 1996
- Country
- ALAB United States
- FMS Germany
- Employees
- ALAB N/A
- FMS N/A
- Industry
- ALAB
- FMS Misc Health and Biotechnology Services
- Sector
- ALAB
- FMS Health Care
- Exchange
- ALAB NYSE
- FMS Nasdaq
- Market Cap
- ALAB 15.0B
- FMS 15.9B
- IPO Year
- ALAB 2024
- FMS 1996
- Fundamental
- Price
- ALAB $95.79
- FMS $27.05
- Analyst Decision
- ALAB Strong Buy
- FMS Hold
- Analyst Count
- ALAB 15
- FMS 1
- Target Price
- ALAB $97.50
- FMS $30.00
- AVG Volume (30 Days)
- ALAB 4.9M
- FMS 345.7K
- Earning Date
- ALAB 08-05-2025
- FMS 07-29-2025
- Dividend Yield
- ALAB N/A
- FMS 2.11%
- EPS Growth
- ALAB N/A
- FMS 27.83
- EPS
- ALAB 0.26
- FMS 2.28
- Revenue
- ALAB $490,474,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- ALAB $80.73
- FMS $2.74
- Revenue Next Year
- ALAB $28.94
- FMS $3.60
- P/E Ratio
- ALAB $382.08
- FMS $23.76
- Revenue Growth
- ALAB 200.19
- FMS 0.10
- 52 Week Low
- ALAB $36.22
- FMS $17.93
- 52 Week High
- ALAB $147.39
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- ALAB N/A
- FMS 39.69
- Support Level
- ALAB N/A
- FMS $26.16
- Resistance Level
- ALAB N/A
- FMS $28.87
- Average True Range (ATR)
- ALAB 0.00
- FMS 0.31
- MACD
- ALAB 0.00
- FMS -0.12
- Stochastic Oscillator
- ALAB 0.00
- FMS 12.92
About ALAB ASTERA LABS INC
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.